Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation
about
Glucose, VEGF-A, and diabetic complicationsProteomic-based detection of a protein cluster dysregulated during cardiovascular development identifies biomarkers of congenital heart defectsVascular remodeling of the mouse yolk sac requires hemodynamic force.Heart valve development: endothelial cell signaling and differentiationVEGF-A and Semaphorin3A: modulators of vascular sympathetic innervation.The Ras activator RasGRP3 mediates diabetes-induced embryonic defects and affects endothelial cell migration.The interplay between glucose and fatty acids on tube formation and fatty acid uptake in the first trimester trophoblast cells, HTR8/SVneo.Role of HIF-1α in maternal hyperglycemia-induced embryonic vasculopathyDiabetic angiopathy and angiogenic defects.Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2.Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular developmentImpact of maternal diabetes on epigenetic modifications leading to diseases in the offspringNew development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects.Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats.Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.High glucose induces human endothelial dysfunction through an Axl-dependent mechanismPlacental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease?The diabetic pregnancy and offspring blood pressure in childhood: a systematic review and meta-analysis.Enhancing and diminishing gene function in human embryonic stem cells.Glucose regulates insulin mitogenic effect by modulating SHP-2 activation and localization in JAr cells.Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model.Hyperglycemia-induced apoptosis affects sex ratio of bovine and murine preimplantation embryos.Delay in rat lung alveolarization after the combined exposure of maternal hyperglycemia and postnatal hyperoxia.Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats.Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose.Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients.
P2860
Q28362039-5F7947B6-677C-42EA-8671-4E900387B9ECQ28509745-9DD60EFB-EC50-4733-9F91-EBF1C563398AQ30606149-946FDED3-EDA8-4552-9408-4279A3C485EFQ33607338-044BED20-58A4-45A6-B06E-3430B7A9CEDEQ33854486-0BB32597-F4B7-4750-B8C8-129180180C24Q34176721-7476321A-BB91-49F2-B29B-7E065C3B7F4FQ34448828-BE80ED35-49C9-4481-83DB-70CE68B08DDDQ35414159-48652EE9-CDFC-41C3-BC8E-5594F8BD0982Q36301365-3A483C12-A0CF-43AA-A19B-1096221EEE3DQ36325010-2956B262-61B9-4DAC-BA82-ECAB2A6FB1C9Q36330450-E7CFBC56-57DD-4EF0-993E-564A4C087ACBQ36440116-08805B6E-DC5C-4E3A-9A14-6DD3F9CF952EQ36553779-F8F6F9CF-D5FC-445D-8F47-4FE3B26EFAA0Q36975500-F2CEC844-FB2A-484C-8AB8-3F251F484834Q37163557-79846A28-303B-4B16-B714-6F9263263D0BQ37615975-58EEC197-AB97-4378-BF6A-A80A8F9210CDQ37854856-00537495-EA92-45FC-917D-6D4EC539CD8FQ38040657-A95EE279-1DD6-4254-8D7C-C7A93E57F354Q40605159-6BA6B9D5-1FE7-4935-91FD-0692846AD9F2Q42520808-70CC1BB4-B2A0-49C8-8345-6E124B7C2F9DQ44185509-B66CD735-8CA5-48ED-AE7A-4E90DF0AE572Q44409634-0019D561-D30F-4324-9B4D-9BC3D9FFC57CQ44488466-12A3CECA-6371-4E59-A17D-7CD85ED74CEDQ45172678-F864AB42-7C05-4EFF-AC9E-6BD91BD8BA75Q46379963-7CC34A6A-2E4F-4D91-980A-E0990C8C12DCQ47941819-41E36730-67B0-4057-81E9-69B24A44BFDA
P2860
Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@ast
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@en
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@nl
type
label
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@ast
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@en
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@nl
prefLabel
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@ast
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@en
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@nl
P2093
P2860
P1476
Hyperglycemia-induced vasculop ...... n and VEGF receptor activation
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)64069-2
P407
P50
P577
2001-04-01T00:00:00Z